1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Adebrelimab (SHR-1316): new trials by email Literature Review of Adebrelimab (SHR-1316) trials Research Report on Adebrelimab (SHR-1316)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer Adebrelimab;decitabine; - Adebrelimab (SHR-1316), Decitabine | Phase 1 / Phase 2 | Recruiting | Tianjin Medical University Cancer Institute and Hospital | 20 | 2024-06-15 | 2024-06-28 |
Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Pancreatic Diseases (1)
Tianjin Medical University Cancer Institute and Hospital (1)
China (1)